Concepedia

LaKesla R. Iles

LR

Statistics

Publications

3

Citations

147

H-Index

3

Active since

2017

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

LaKesla R. Iles is an author at The University of Texas MD Anderson Cancer Center specializing in cell signaling, systems pharmacology, and tumor biology.

ORCID

Top concepts

Publications per year

2017–2022

3

Publications

3

Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability

Hailing Yang, Weiqun Mao, Cristian Rodriguez‐Aguayo et al. · Clinical Cancer Research · 2018 · 54 citations

Pirtobrutinib inhibits wild-type and mutant Bruton’s tyrosine kinase-mediated signaling in chronic lymphocytic leukemia

Burcu Aslan, LaKesla R. Iles, Ganiraju C. Manyam et al. · Blood Cancer Journal · 2022 · 54 citations · Full text

, , +16

Genome-wide siRNA screen identifies UNC50 as a regulator of Shiga toxin 2 trafficking

Andrey S. Selyunin, LaKesla R. Iles, Geoffrey Bartholomeusz et al. · The Journal of Cell Biology · 2017 · 39 citations · Full text

1–3 of 3